KARUS THERAPEUTICS LIMITED

Company Name
KARUS THERAPEUTICS LIMITED

Legal Registered Office
C/O CORK GULLY LLP 40 Villiers Street London WC2N 6NJ Other companies in OX14

Company Number		05490954
Company ID Number		05490954
Date formed		2005-06-24
Country
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Liquidation
Lastest accounts		2023-06-30
Account next due		31/03/2025
Latest return		2023-06-24
Return next due		22/07/2017
Type of accounts		TOTAL EXEMPTION FULL
VAT Number /Sales tax ID		~~GB871412633~~

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of KARUS THERAPEUTICS LIMITED

Current Directors

Officer	Role	Date Appointed
SIMON JONES	Company Secretary	2013-03-21
CATHERINE ELIZABETH BINGHAM	Director	2016-04-05
MARTIN WILLIAM EDWARDS	Director	2012-06-12
LIAM THOMAS RATCLIFFE	Director	2013-02-04
STEPHEN JOSEPH SHUTTLEWORTH	Director	2008-07-24

Previous Officers

Officer	Role	Date Appointed	Date Resigned
SIMON KERRY	Director	2006-04-24	2017-05-15
GRAHAM JOHN BOULNOIS	Director	2012-06-12	2016-04-04
WILLIAM DRUMMOND PARIS	Director	2006-10-18	2014-07-24
SAMUEL CAMERON WILLIAMS	Director	2012-06-12	2014-02-04
JUSTINE KING	Company Secretary	2011-05-25	2013-03-21
SRINIVAS AKKARAJU	Director	2012-06-12	2013-02-04
WILLIAM ARTHUR BAINS	Director	2005-07-21	2012-06-12
ANN VERONICA HACKER	Director	2008-04-04	2012-06-12
TUULA KRISTIINA MOILANEN	Company Secretary	2010-03-28	2011-05-25
GRAHAM KEITH PACKHAM	Director	2010-01-01	2010-10-29
SUSAN MARGARET SUNDSTROM	Director	2005-06-30	2010-05-28
GORDON JOHN RANDELL	Company Secretary	2010-01-05	2010-03-29
KATIE EMMA PAYNE	Company Secretary	2009-03-09	2010-01-05
ARASU GANESAN	Director	2005-06-24	2010-01-01
JULIETTE BAKER	Company Secretary	2008-06-12	2009-03-09
IP2IPO SERVICES LIMITED	Director	2006-06-06	2009-02-18
GRAHAM KEITH PACKHAM	Director	2005-06-24	2008-07-25
JAMES CHRISTOPHER TAYLOR	Director	2005-07-25	2008-06-13
DERRICK CHARLES MURRAY	Company Secretary	2007-06-18	2008-06-12
JULIETTE BAKER	Company Secretary	2005-06-24	2007-06-18
ANDREW MACKIE	Director	2005-09-27	2006-06-06
JAMES PETER WILLCOCKS	Director	2005-07-21	2005-09-27
SWIFT INCORPORATIONS LIMITED	Nominated Secretary	2005-06-24	2005-06-24
INSTANT COMPANIES LIMITED	Nominated Director	2005-06-24	2005-06-24

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
LIAM THOMAS RATCLIFFE	CALCHAN HOLDINGS LIMITED	Director	2011-10-03	CURRENT	2011-02-25	Liquidation
STEPHEN JOSEPH SHUTTLEWORTH	OVAL (2265) LIMITED	Director	2017-05-15	CURRENT	2013-07-22	Active - Proposal to Strike off

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-11-09		Final Gazette dissolved via compulsory strike-off
2024-08-09		Voluntary liquidation. Notice of members return of final meeting
2023-09-15		30/06/23 ACCOUNTS TOTAL EXEMPTION FULL
2023-07-26		DIRECTOR APPOINTED MR JAMES ALLISTER JOHN COSTINE
2023-07-21		APPOINTMENT TERMINATED, DIRECTOR HOUMAN ASHRAFIAN
2023-07-13		CONFIRMATION STATEMENT MADE ON 24/06/23, WITH UPDATES
2023-07-11		Termination of appointment of Simon Jones on 2023-07-01
2023-07-11		Appointment of Mr Timothy Edwards as company secretary on 2023-07-01
2023-07-06		REGISTERED OFFICE CHANGED ON 06/07/23 FROM Building 173 - Harwell Innovation Centre Curie Avenue Harwell Science & Innovation Campus Didcot Oxfordshire OX11 0QG United Kingdom
2023-06-21		SMALL COMPANY ACCOUNTS MADE UP TO 30/06/22
2022-09-30		FULL ACCOUNTS MADE UP TO 30/06/21
2022-09-30	AA	FULL ACCOUNTS MADE UP TO 30/06/21
2022-08-15	CS01	CONFIRMATION STATEMENT MADE ON 24/06/22, WITH UPDATES
2021-09-28	AA	FULL ACCOUNTS MADE UP TO 31/12/20
2021-08-25	AD01	REGISTERED OFFICE CHANGED ON 25/08/21 FROM Genesis Building Library Avenue Harwell Campus Didcot Oxfordshire OX11 0SG England
2021-07-29	AA01	Previous accounting period shortened from 31/12/21 TO 30/06/21
2021-07-27	CS01	CONFIRMATION STATEMENT MADE ON 24/06/21, WITH UPDATES
2021-05-05	SH01	26/04/21 STATEMENT OF CAPITAL GBP 13808.38
2021-04-28	SH01	20/04/21 STATEMENT OF CAPITAL GBP 13799.09
2021-04-15	SH01	10/04/21 STATEMENT OF CAPITAL GBP 13388.93
2021-02-02	SH01	20/01/21 STATEMENT OF CAPITAL GBP 13381.29
2020-10-12	AP01	DIRECTOR APPOINTED DR THOMAS PETER DYRBERG
2020-10-09	TM01	APPOINTMENT TERMINATED, DIRECTOR MARTIN WILLIAM EDWARDS
2020-10-09	SH01	07/10/20 STATEMENT OF CAPITAL GBP 13093.95
2020-07-06	CS01	CONFIRMATION STATEMENT MADE ON 24/06/20, WITH UPDATES
2020-05-26	AA	FULL ACCOUNTS MADE UP TO 31/12/19
2020-03-23	RP04SH01	Second filing of capital allotment of shares GBP13,089.38
2020-02-07	SH01	31/12/19 STATEMENT OF CAPITAL GBP 13089.38
2020-01-21	SH01	06/01/20 STATEMENT OF CAPITAL GBP 8265.34
2019-09-27	AA	FULL ACCOUNTS MADE UP TO 31/12/18
2019-09-18	SH01	16/09/19 STATEMENT OF CAPITAL GBP 8177.52
2019-09-18	TM01	APPOINTMENT TERMINATED, DIRECTOR STEPHEN JOSEPH SHUTTLEWORTH
2019-08-16	SH01	17/07/19 STATEMENT OF CAPITAL GBP 8077.52
2019-07-09	CS01	CONFIRMATION STATEMENT MADE ON 24/06/19, WITH UPDATES
2019-07-08	AP01	DIRECTOR APPOINTED MR RONALD HUNT
2019-07-08	SH01	29/04/19 STATEMENT OF CAPITAL GBP 8059.18
2019-05-20	TM01	APPOINTMENT TERMINATED, DIRECTOR LIAM THOMAS RATCLIFFE
2019-02-07	AP01	DIRECTOR APPOINTED PROFESSOR HOUMAN ASHRAFIAN
2019-02-06	TM01	APPOINTMENT TERMINATED, DIRECTOR CATHERINE ELIZABETH BINGHAM
2019-02-06	SH01	01/01/19 STATEMENT OF CAPITAL GBP 8057.64
2018-12-20	SH01	01/12/18 STATEMENT OF CAPITAL GBP 8024.54
2018-11-16	AP01	DIRECTOR APPOINTED MR TIMOTHY EDWARDS
2018-10-29	SH01	01/10/18 STATEMENT OF CAPITAL GBP 8011.31
2018-09-25	RES10	Resolutions passed: Resolution of allotment of securities
2018-08-10	LATEST SOC	10/08/18 STATEMENT OF CAPITAL;GBP 7968.56
2018-08-10	SH01	17/07/18 STATEMENT OF CAPITAL GBP 7968.56
2018-07-08	CS01	CONFIRMATION STATEMENT MADE ON 24/06/18, WITH UPDATES
2018-05-14	LATEST SOC	14/05/18 STATEMENT OF CAPITAL;GBP 7932.48
2018-05-14	SH01	08/05/18 STATEMENT OF CAPITAL GBP 7932.48
2018-05-02	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/12/17
2018-04-16	SH01	05/04/18 STATEMENT OF CAPITAL GBP 7920.52
2017-12-21	AA01	Current accounting period shortened from 31/03/18 TO 31/12/17
2017-12-07	LATEST SOC	07/12/17 STATEMENT OF CAPITAL;GBP 7849.83
2017-12-07	SH01	07/12/17 STATEMENT OF CAPITAL GBP 7849.83
2017-12-07	SH01	30/10/17 STATEMENT OF CAPITAL GBP 7816.98
2017-10-16	AA	SMALL COMPANY ACCOUNTS MADE UP TO 31/03/17
2017-09-26	RES01	ADOPT ARTICLES 26/09/17
2017-08-03	PSC08	NOTIFICATION OF PSC STATEMENT ON 03/08/2017
2017-07-07	CS01	CONFIRMATION STATEMENT MADE ON 24/06/17, WITH UPDATES
2017-06-05	TM01	APPOINTMENT TERMINATED, DIRECTOR SIMON KERRY
2017-05-16	LATEST SOC	16/05/17 STATEMENT OF CAPITAL;GBP 7809.39
2017-05-16	SH01	16/05/17 STATEMENT OF CAPITAL GBP 7809.39
2017-05-16	SH01	31/03/17 STATEMENT OF CAPITAL GBP 7657.32
2017-03-08	AA	FULL ACCOUNTS MADE UP TO 30/06/16
2017-01-31	SH01	06/01/17 STATEMENT OF CAPITAL GBP 7656.63
2017-01-31	SH01	15/10/16 STATEMENT OF CAPITAL GBP 7478.88
2016-12-23	AA01	CURRSHO FROM 30/06/2017 TO 31/03/2017
2016-10-18	AD01	REGISTERED OFFICE CHANGED ON 18/10/2016 FROM GENESIS BUILDING LIBRARY AVENUE HARWELL OXFORD DIDCOT OXFORDSHIRE OX11 0SG ENGLAND
2016-10-18	AD01	REGISTERED OFFICE CHANGED ON 18/10/2016 FROM GENESIS BUILDING LIBRARY AVENUE HARWELL CAMPUS DIDCOT OXFORDSHIRE OX11 0QS ENGLAND
2016-10-13	AD01	REGISTERED OFFICE CHANGED ON 13/10/2016 FROM GENESIS BUILDING LIBRARY AVENUE HARWELL CAMPUS DIDCOT OXFORDSHIRE OX11 0QS ENGLAND
2016-09-30	AD01	REGISTERED OFFICE CHANGED ON 30/09/2016 FROM 93 INNOVATION DRIVE, MILTON PARK ABINGDON OXFORDSHIRE OX14 4RZ ENGLAND
2016-08-16	LATEST SOC	16/08/16 STATEMENT OF CAPITAL;GBP 7473.64
2016-08-16	AR01	24/06/16 FULL LIST
2016-06-10	LATEST SOC	10/06/16 STATEMENT OF CAPITAL;GBP 3899.3;USD 3574.34
2016-06-10	SH01	06/05/16 STATEMENT OF CAPITAL GBP 3899.30 06/05/16 STATEMENT OF CAPITAL USD 3574.34
2016-04-21	TM01	APPOINTMENT TERMINATED, DIRECTOR GRAHAM BOULNOIS
2016-04-21	AP01	DIRECTOR APPOINTED MS CATHERINE ELIZABETH BINGHAM
2015-12-18	AA	FULL ACCOUNTS MADE UP TO 30/06/15
2015-11-11	LATEST SOC	11/11/15 STATEMENT OF CAPITAL;GBP 3077.83;USD 2489.72
2015-11-11	SH01	30/09/15 STATEMENT OF CAPITAL GBP 3077.83 30/09/15 STATEMENT OF CAPITAL USD 2489.72
2015-11-03	RES13	LIMIT SHARE CAP £8,450.46 26/08/2015
2015-11-03	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2015-11-03	SH01	21/09/15 STATEMENT OF CAPITAL GBP 5562.31
2015-08-26	AR01	24/06/15 FULL LIST
2015-01-08	AA	FULL ACCOUNTS MADE UP TO 30/06/14
2014-09-10	LATEST SOC	10/09/14 STATEMENT OF CAPITAL;GBP 4568.11
2014-09-10	AR01	24/06/14 CHANGES
2014-08-20	TM01	APPOINTMENT TERMINATED, DIRECTOR WILLIAM PARIS
2014-08-20	TM01	APPOINTMENT TERMINATED, DIRECTOR SAMUEL WILLIAMS
2014-02-19	SH01	04/02/14 STATEMENT OF CAPITAL GBP 4568.11
2014-02-18	SH01	11/10/13 STATEMENT OF CAPITAL GBP 2331.44
2013-10-10	AA	FULL ACCOUNTS MADE UP TO 30/06/13
2013-08-15	AD01	REGISTERED OFFICE CHANGED ON 15/08/2013 FROM 93 MILTON PARK ABINGDON OXFORDSHIRE OX14 4RZ UNITED KINGDOM
2013-08-08	AR01	24/06/13 NO MEMBER LIST
2013-07-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM DRUMMOND PARIS / 29/07/2013
2013-07-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM DRUMMOND PARIS / 29/07/2013
2013-07-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM DRUMMOND PARIS / 29/07/2013
2013-07-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM DRUMMOND PARIS / 29/07/2013
2013-07-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM DRUMMOND PARIS / 29/07/2013
2013-07-29	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR STEPHEN JOSEPH SHUTTLEWORTH / 29/07/2013
2013-07-29	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR SIMON KERRY / 29/07/2013
2013-03-27	AD01	REGISTERED OFFICE CHANGED ON 27/03/2013 FROM 93 INNOVATION DRIVE MILTON PARK MILTON ABINGDON OXFORDSHIRE OX14 4RZ ENGLAND
2013-03-27	AP03	SECRETARY APPOINTED MR SIMON JONES
2013-03-26	AP01	DIRECTOR APPOINTED DR LIAM THOMAS RATCLIFFE
2013-03-26	TM02	APPOINTMENT TERMINATED, SECRETARY JUSTINE KING
2013-03-04	AD01	REGISTERED OFFICE CHANGED ON 04/03/2013 FROM 2 VENTURE ROAD SOUTHAMPTON SCIENCE PARK SOUTHAMPTON HAMPSHIRE SO16 7NP
2013-02-08	TM01	APPOINTMENT TERMINATED, DIRECTOR SRINIVAS AKKARAJU
2012-12-20	AA	FULL ACCOUNTS MADE UP TO 30/06/12
2012-09-04	TM01	APPOINTMENT TERMINATED, DIRECTOR WILLIAM BAINS
2012-09-04	TM01	APPOINTMENT TERMINATED, DIRECTOR ANN HACKER
2012-08-24	AP01	DIRECTOR APPOINTED MARTIN WILLIAM EDWARDS
2012-08-13	AP01	DIRECTOR APPOINTED PROFESSOR GRAHAM JOHN BOULNOIS
2012-08-02	AP01	DIRECTOR APPOINTED SRINIVAS AKKARAJU
2012-07-23	AR01	24/06/12 FULL LIST
2012-07-17	AP01	DIRECTOR APPOINTED SAM WILLIAMS
2012-07-17	RES12	VARYING SHARE RIGHTS AND NAMES
2012-07-17	RES01	ADOPT ARTICLES 12/06/2012
2012-07-12	SH06	12/07/12 STATEMENT OF CAPITAL GBP 2304.58
2012-07-12	SH03	RETURN OF PURCHASE OF OWN SHARES
2012-07-11	SH01	13/06/12 STATEMENT OF CAPITAL GBP 2304.58
2012-03-06	AA	FULL ACCOUNTS MADE UP TO 30/06/11
2011-09-19	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-09-13	CH03	SECRETARY'S CHANGE OF PARTICULARS / JUSTINE GUY / 15/08/2011
2011-07-22	AR01	24/06/11 FULL LIST
2011-06-21	AD01	REGISTERED OFFICE CHANGED ON 21/06/2011 FROM 79 GEORGE STREET RYDE ISLE OF WIGHT PO33 2JF UNITED KINGDOM
2011-06-21	TM02	APPOINTMENT TERMINATED, SECRETARY TUULA MOILANEN
2011-06-21	AP03	SECRETARY APPOINTED JUSTINE GUY
2011-06-21	TM01	APPOINTMENT TERMINATED, DIRECTOR GRAHAM PACKHAM
2011-03-30	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-03-01	AA	FULL ACCOUNTS MADE UP TO 30/06/10
2010-09-07	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2010-07-09	AUD	AUDITOR'S RESIGNATION
2010-07-08	MISC	RE AUDS RES
2010-07-01	AR01	24/06/10 FULL LIST
2010-07-01	TM01	APPOINTMENT TERMINATED, DIRECTOR SUSAN SUNDSTROM
2010-06-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR STEPHEN JOSEPH SHUTTLEWORTH / 24/06/2010
2010-06-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR SIMON KERRY / 24/06/2010
2010-06-30	TM01	APPOINTMENT TERMINATED, DIRECTOR SUSAN SUNDSTROM
2010-05-27	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2010-05-27	RES01	ADOPT ARTICLES 13/04/2010
2010-05-07	AP01	DIRECTOR APPOINTED PROFESSOR GRAHAM KEITH PACKHAM
2010-04-30	TM01	APPOINTMENT TERMINATED, DIRECTOR ARASU GANESAN
2010-04-30	AD01	REGISTERED OFFICE CHANGED ON 30/04/2010 FROM FINANCE DEPARTMENT HIGHFIELD SOUTHAMPTON SO17 1BJ
2010-04-30	TM02	APPOINTMENT TERMINATED, SECRETARY GORDON RANDELL
2010-04-30	AP03	SECRETARY APPOINTED MRS TUULA KRISTIINA MOILANEN
2010-01-13	AP03	SECRETARY APPOINTED MR GORDON JOHN RANDELL
2010-01-13	TM02	APPOINTMENT TERMINATED, SECRETARY KATIE PAYNE
2009-11-13	AA	FULL ACCOUNTS MADE UP TO 30/06/09
2009-07-22	363a	RETURN MADE UP TO 24/06/09; FULL LIST OF MEMBERS
2009-06-02	288c	DIRECTOR'S CHANGE OF PARTICULARS / ANN HACKER / 01/06/2009
2009-03-11	288a	SECRETARY APPOINTED MISS KATIE EMMA PAYNE

Industry Information

SIC/NAIC Codes

72 - Scientific research and development

721 - Research and experimental development on natural sciences and engineering

72190 - Other research and experimental development on natural sciences and engineering

Licences & Regulatory approval

We could not find any licences issued to KARUS THERAPEUTICS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

Resolutions for Winding-up	2023-12-15
Appointment of Liquidators	2023-12-15

Fines / Sanctions

No fines or sanctions have been issued against KARUS THERAPEUTICS LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	0
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	0

Details of Mortgagee Charges

KARUS THERAPEUTICS LIMITED does not have any mortgage charges so there is no mortgagee data available

	Average	Max
MortgagesNumMortCharges	0.38	9
MortgagesNumMortOutstanding	0.21	9
MortgagesNumMortPartSatisfied	0.00	1
MortgagesNumMortSatisfied	0.17	9

This shows the max and average number of mortgages for companies with the same SIC code of 72190 - Other research and experimental development on natural sciences and engineering

Filed Financial Reports

Annual Accounts
2021-06-30

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on KARUS THERAPEUTICS LIMITED

Intangible Assets

Patents

Intellectual Property Patents Registered by KARUS THERAPEUTICS LIMITED

KARUS THERAPEUTICS LIMITED has registered 3 patents

GB2460178 , GB2460180 , GB2460181 ,

Domain Names

We do not have the domain name information for KARUS THERAPEUTICS LIMITED

Trademarks

We have not found any records of KARUS THERAPEUTICS LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for KARUS THERAPEUTICS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as KARUS THERAPEUTICS LIMITED are:

OAKLEA LTD.	£ 237,880
TRL LIMITED	£ 130,521
SGS MIS ENVIRONMENTAL LTD	£ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 13,354
WILDKNOWLEDGE LTD	£ 8,604
FONTENERGY LTD	£ 4,300
T-CUBED LTD	£ 2,599
MARWELL WILDLIFE	£ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED	£ 1,000
SITE ANALYTICAL SERVICES LIMITED	£ 950
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000

Outgoings

Business Rates/Property Tax

No properties were found where KARUS THERAPEUTICS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Import/Export of Goods

Goods imported/exported by KARUS THERAPEUTICS LIMITED

Date	Import Code	Imported Goods classification description
2018-12-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-12-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-11-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-11-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-11-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-11-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-09-00	84212980
2018-09-00	84212980
2018-06-00	29420000	Separate chemically defined organic compounds, n.e.s.
2018-06-00	29420000	Separate chemically defined organic compounds, n.e.s.
2018-05-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-05-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2018-01-00	29420000	Separate chemically defined organic compounds, n.e.s.
2018-01-00	29420000	Separate chemically defined organic compounds, n.e.s.
2016-11-00	30049000	Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2016-06-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-04-00	38210000	Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells
2016-03-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-11-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-10-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-01	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-06-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-06-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-01	29
2015-04-01	29420000	Separate chemically defined organic compounds, n.e.s.
2015-04-00	29
2015-04-00	29420000	Separate chemically defined organic compounds, n.e.s.
2015-03-01	29143900	Ketones, aromatic, without other oxygen function (excl. phenylacetone [phenylpropan-2-one])
2015-03-01	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-03-01	29420000	Separate chemically defined organic compounds, n.e.s.
2015-03-00	29143900	Ketones, aromatic, without other oxygen function (excl. phenylacetone [phenylpropan-2-one])
2015-03-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-03-00	29420000	Separate chemically defined organic compounds, n.e.s.
2015-02-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-02-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-01-01	28100090	Oxides of boron and boric acids (excl. diboron trioxide)
2015-01-01	29420000	Separate chemically defined organic compounds, n.e.s.
2015-01-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-01-00	28100090	Oxides of boron and boric acids (excl. diboron trioxide)
2015-01-00	29420000	Separate chemically defined organic compounds, n.e.s.
2015-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-12-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-10-01	29142900	Cyclanic, cyclenic or cycloterpenic ketones, without other oxygen function (excl. cyclohexanone, methylcyclohexanones, ionones and methylionones)
2014-10-01	29335995	Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
2014-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-09-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-08-01	29334990	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing in the structure a quinoline or isoquinoline ring-system, whether or not hydrogenated, but not further fused (excl. levorphanol "INN", dextromethorphan "INN", and their salts, halogen derivatives of quinoline, quinolinecarboxylic acid derivatives, and inorganic or organic compounds of mercury)
2014-08-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-04-01	29321100	Tetrahydrofuran
2014-04-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-03-01	30069200	Waste pharmaceuticals
2014-03-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-02-01	29319090	Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2014-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
2014-02-01	30069200	Waste pharmaceuticals
2014-02-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-01-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-12-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
2013-10-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
2013-08-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-07-01	29420000	Separate chemically defined organic compounds, n.e.s.
2013-07-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-05-01	29420000	Separate chemically defined organic compounds, n.e.s.
2013-05-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-12-01	90278099	Non-electronic instruments and apparatus for physical or chemical analysis or for determining surface tension or the like, or for measuring heat or sound, n.e.s.
2010-02-01	29420000	Separate chemically defined organic compounds, n.e.s.

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards

Technology Strategy Board Awards

The Technology Strategy Board has not awarded KARUS THERAPEUTICS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR

European Union CORDIS Awards

The European Union has not awarded KARUS THERAPEUTICS LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

Last Datalog update:	2024-11-09 11:50:40
Primary Source:	Companies House

Company Overview

Company Officers of KARUS THERAPEUTICS LIMITED

Related Directorships

Intellectual Property Patents Registered by KARUS THERAPEUTICS LIMITED